EUVIMEDEUVIMED entdecken
Open Access

Epstein-Barr Virus Antibody Response Patterns in Endemic and Nonendemic Cases of Nasopharyngeal Carcinoma

Ilona Argirion iD, Aisha Babi iD, Julia Simon, Tim Waterboer iD, Wan-Lun Hsu, Chien-Jen Chen iD, Kelly J Yu iD, Miranda Pring iD, Katrina Hurley, Allan Hildesheim iD, Zhiwei Liu iD

The Journal of Infectious Diseases · 2026

DOI: 10.1093/infdis/jiaf526 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Ilona Argirion und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Science, School of Health, Georgetown University Medical Center, Washington, DC. Hauptthemen laut MEDLINE: Antibodies, Viral, Nasopharyngeal Neoplasms, Herpesvirus 4, Human, Epstein-Barr Virus Infections. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein-Barr virus (EBV) causes most nasopharyngeal carcinoma (NPC), a malignancy endemic in certain regions, presenting with nonspecific symptoms and lacking a robust minimally invasive biomarker. To assess previously developed multiplex Luminex assay EBV antibody signatures in a nonendemic population, we analyzed and compared 98 NPC sera and 142 matched controls from the nonendemic Head and Neck 5000 clinical cohort against an endemic Taiwan case-control cohort. All models, except the 2-antibody IgA panel, performed similarly, achieving 90%–99% accuracy in identifying EBV-positive NPC. Our results showed that EBV antibody panels can accurately define EBV-positive NPC regardless of endemicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralNasopharyngeal NeoplasmsHerpesvirus 4, HumanEpstein-Barr Virus InfectionsHumansNasopharyngeal CarcinomaCarcinomaMaleFemaleTaiwanEndemic DiseasesMiddle AgedCase-Control StudiesAdultImmunoglobulin AAged

Stichwörter der Autor:innen

Epstein-Barr virusantibodiesendemicityhumoral immune responsenasopharyngeal carcinoma

Substanzen

Antibodies, ViralImmunoglobulin A

Autor:innen und Institutionen

  • Department of Human Science, School of Health, Georgetown University Medical Center, Washington, DC.
  • Division of Infections and Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Data Science Center.
  • Master Program of Big Data in Medical Healthcare Industry, College of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan.
  • Genomics Research Center, Academica Sinica, Taipei, Taiwan.
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.

ORCID-Profile: Ilona Argirion, Aisha Babi, Tim Waterboer, Chien-Jen Chen, Kelly J Yu, Miranda Pring, Allan Hildesheim, Zhiwei Liu

Zitieren

APA

Argirion, I., Babi, A., Simon, J., Waterboer, T., Hsu, W. L., Chen, C. J., Yu, K. J., Pring, M., Hurley, K., Hildesheim, A., & Liu, Z. (2026). Epstein-Barr Virus Antibody Response Patterns in Endemic and Nonendemic Cases of Nasopharyngeal Carcinoma. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf526

Vancouver

Argirion I, Babi A, Simon J, Waterboer T, Hsu WL, Chen CJ, et al. Epstein-Barr Virus Antibody Response Patterns in Endemic and Nonendemic Cases of Nasopharyngeal Carcinoma. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiaf526

BibTeX
@article{Argirion2026,
  author = {Argirion, Ilona and Babi, Aisha and Simon, Julia and Waterboer, Tim and Hsu, Wan-Lun and Chen, Chien-Jen and Yu, Kelly J and Pring, Miranda and Hurley, Katrina and Hildesheim, Allan and Liu, Zhiwei},
  title = {Epstein-Barr Virus Antibody Response Patterns in Endemic and Nonendemic Cases of Nasopharyngeal Carcinoma},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiaf526}
}
Kostenlos starten →